Chronic Periodontitis — Pre-procedural Mouthwash in Reducing Bacteria in Dental Aerosols
Citation(s)
Bentley CD, Burkhart NW, Crawford JJ Evaluating spatter and aerosol contamination during dental procedures. J Am Dent Assoc. 1994 May;125(5):579-84.
Cochran MA, Miller CH, Sheldrake MA The efficacy of the rubber dam as a barrier to the spread of microorganisms during dental treatment. J Am Dent Assoc. 1989 Jul;119(1):141-4.
Costa X, Laguna E, Herrera D, Serrano J, Alonso B, Sanz M Efficacy of a new mouth rinse formulation based on 0.07% cetylpyridinium chloride in the control of plaque and gingivitis: a 6-month randomized clinical trial. J Clin Periodontol. 2013 Nov;40(11):
Erovic Ademovski S, Lingström P, Renvert S The effect of different mouth rinse products on intra-oral halitosis. Int J Dent Hyg. 2016 May;14(2):117-23. doi: 10.1111/idh.12148. Epub 2015 May 31.
Feres M, Figueiredo LC, Faveri M, Stewart B, de Vizio W The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office. J Am Dent Assoc. 2010 Apr;141(4):415-22.
Giertsen E Effects of mouthrinses with triclosan, zinc ions, copolymer, and sodium lauryl sulphate combined with fluoride on acid formation by dental plaque in vivo. Caries Res. 2004 Sep-Oct;38(5):430-5.
Grenier D Quantitative analysis of bacterial aerosols in two different dental clinic environments. Appl Environ Microbiol. 1995 Aug;61(8):3165-8.
Gupta G, Mitra D, Ashok KP, Gupta A, Soni S, Ahmed S, Arya A Efficacy of preprocedural mouth rinsing in reducing aerosol contamination produced by ultrasonic scaler: a pilot study. J Periodontol. 2014 Apr;85(4):562-8. doi: 10.1902/jop.2013.120616. Epub 2013 Jul 15.
Harrel SK, Molinari J Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc. 2004 Apr;135(4):429-37. Review.
Jones CG Chlorhexidine: is it still the gold standard? Periodontol 2000. 1997 Oct;15:55-62. Review.
Kang JH, Jang YJ, Kim DJ, Park JW Antimicrobial effectiveness of cetylpyridinium chloride and zinc chloride-containing mouthrinses on bacteria of halitosis and peri-implant disease. Int J Oral Maxillofac Implants. 2015 Nov-Dec;30(6):1341-7. doi: 10.11607
Kaur R, Singh I, Vandana KL, Desai R Effect of chlorhexidine, povidone iodine, and ozone on microorganisms in dental aerosols: randomized double-blind clinical trial. Indian J Dent Res. 2014 Mar-Apr;25(2):160-5. doi: 10.4103/0970-9290.135910.
Keni NN, Aras MA, Chitre V Chlorhexidine allergy due to topical application. Indian J Dent Res. 2012 Sep-Oct;23(5):674-6. doi: 10.4103/0970-9290.107393.
Kjaerheim V, Skaare A, Barkvoll P, Rölla G Antiplaque, antibacterial, and anti-inflammatory properties of triclosan mouthrinses in combination with zinc citrate or polyvinylmethylether maleic acid (PVM-MA) copolymer. Eur J Oral Sci. 1996 Oct-Dec;104(5-6):529-34.
Logothetis DD, Martinez-Welles JM Reducing bacterial aerosol contamination with a chlorhexidine gluconate pre-rinse. J Am Dent Assoc. 1995 Dec;126(12):1634-9.
Mendes L, Coimbra J, Pereira AL, Resende M, Pinto MG Comparative effect of a new mouthrinse containing chlorhexidine, triclosan and zinc on volatile sulphur compounds: a randomized, crossover, double-blind study. Int J Dent Hyg. 2016 Aug;14(3):202-8. doi: 10.1111/idh.12132. Epub 2015 Feb 26.
Pandit S, Cai JN, Jung JE, Lee YS, Jeon JG Effect of brief cetylpyridinium chloride treatments during early and mature cariogenic biofilm formation. Oral Dis. 2015 Jul;21(5):565-71. doi: 10.1111/odi.12312. Epub 2015 Feb 13.
Rivera-Hidalgo F, Barnes JB, Harrel SK Aerosol and splatter production by focused spray and standard ultrasonic inserts. J Periodontol. 1999 May;70(5):473-7.
Shetty SK, Sharath K, Shenoy S, Sreekumar C, Shetty RN, Biju T Compare the effcacy of two commercially available mouthrinses in reducing viable bacterial count in dental aerosol produced during ultrasonic scaling when used as a preprocedural rinse. J Con
Thomas E Efficacy of two commonly available mouth rinses used as preprocedural rinses in children. J Indian Soc Pedod Prev Dent. 2011 Apr-Jun;29(2):113-6. doi: 10.4103/0970-4388.84682.
Toroglu MS, Haytaç MC, Köksal F Evaluation of aerosol contamination during debonding procedures. Angle Orthod. 2001 Aug;71(4):299-306.
Varoni E, Tarce M, Lodi G, Carrassi A Chlorhexidine (CHX) in dentistry: state of the art. Minerva Stomatol. 2012 Sep;61(9):399-419. Review. English, Italian.
Veena HR, Mahantesha S, Joseph PA, Patil SR, Patil SH Dissemination of aerosol and splatter during ultrasonic scaling: a pilot study. J Infect Public Health. 2015 May-Jun;8(3):260-5. doi: 10.1016/j.jiph.2014.11.004. Epub 2015 Jan 3.
Yengopal V The use of essential oil mouthwashes as preprocedural rinses for infection control. SADJ. 2004 Jul;59(6):247-8, 250.
Effectiveness of a Pre-procedural Mouthwash in Reducing Bacteria in Dental Aerosols and Splatters: a Randomized Clinical Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
